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Three-dimensional microscopic analysis of clinical prostate specimens
Aims: Microscopic evaluation of prostate specimens
for both clinical and research purposes is generally
performed on 5-lm-thick tissue sections. Because
cross-sections give a two-dimensional (2D) represen-
tation, little is known about the actual underlying
three-dimensional (3D) architectural features of
benign prostate tissue and prostate cancer (PCa). The
aim of this study was to show that a combination of
tissue-clearing protocols and confocal microscopy can
successfully be applied to investigate the 3D architec-
ture of human prostate tissue.
Methods and results: Optical clearing of intact fresh
and formalin-fixed paraffin-embedded (FFPE) clinical
prostate specimens allowed us to visualize tissue
structures up to a depth of 800 lm, whereas, in
uncleared tissue, detection of fluorescence was only
possible up to 70 lm. Fluorescent labelling with a
general nuclear dye and antibodies against cytoker-
atin (CK) 5 and CK8-18 resulted in comprehensive
3D imaging of benign peripheral and transition pros-
tate zones, as well as individual PCa growth patterns.
After staining, clearing, and imaging, samples could
still be processed for 2D (immuno)histochemical
staining and DNA analysis, enabling additional
molecular and diagnostic characterization of small tis-
sue specimens.
Conclusions: In conclusion, the applicability of 3D
imaging to archival FFPE and fresh clinical specimens
offers unlimited opportunities to study clinical and
biological topics of interest in their actual 3D context.
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Introduction
The Gleason grade is an important parameter for
therapeutic decision-making and predicting the out-
come of patients with clinical prostate cancer (PCa),
and is entirely based on classification of architectural
tumour growth patterns.1 Pathological investigation
for both diagnostic and research purposes is routinely
carried out by microscopic evaluation of 4–5-lm-
thick tissue slides, resulting in a two-dimensional
(2D) tissue cross-section. In fact, little is known about
the actual three-dimensional (3D) architecture of dis-
eases such as PCa.
Three-dimensional microscopic tissue reconstruc-
tion has mostly been carried out by serial sectioning,
staining and imaging of up to hundreds of 2D sec-
tions.2–4 Although developments in image stacking
have improved 3D reconstruction, serial slicing is
laborious and sensitive to tissue deformations.5–8
Confocal laser scanning microscopy (CLSM) allows
fluorescent 3D imaging without the need for section-
ing, but is limited to depths of tens of micrometres,
owing to scattering and absorption of emitted fluores-
cent light. Several protocols have recently been
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developed to optically clear tissue and thereby
enhance the detection of emitted fluorescent light at
increased tissue depths.9–14 Three-dimensional imag-
ing by a combination of tissue clearance and CLSM
has predominantly been used for investigation of
mouse models, sometimes primarily labelled with
green fluorescent protein.13,15,16 The aim of the cur-
rent study was to investigate the feasibility of using
tissue-clearing protocols and imaging techniques on
fresh and formalin-fixed paraffin-embedded (FFPE)
prostate specimens, in order to analyse both clinical
and biological PCa features in their actual 3D con-
text.
Materials and methods
C L I N I C A L S P E C I M E N S
Prostate samples were derived from radical prostatec-
tomies, performed at Erasmus Medical Centre, Rotter-
dam, the Netherlands between September 2014 and
March 2016. The use of fresh and archival tissue
samples for research purposes was approved by the
local Medical Ethical Committee (MEC 2011-295
and 2011-296). After arrival at the pathology
department, fresh samples of 5 9 5 mm from both
normal and tumour tissue were collected for 3D
imaging (N = 13). From each sample, a 1-mm slice
was cut and processed for reference 5-lm slice
haematoxylin and eosin (HE) staining. Tissue sam-
ples for 3D imaging were sliced within 24 h in ice-
cold phosphate-buffered saline (PBS) with a vibrating
blade microtome Leica VT 1200 S (Leica, Rijswijk,
the Netherlands). Slices with a thickness of 500–
1000 lm were fixed overnight in 1% formaldehyde
in PBS at 4°C. After fixation, tissue slices were
washed in PBS, gradually incubated in methanol/
PBS up to 100% methanol, and stored at 20°C
until further processing.
S T A I N I N G O F F O R M A L I N - F I X E D N O N - E M B E D D E D
T I S S U E
Fixation, staining and clearing of fresh, non-
embedded tissue was performed as described
previously.17 Briefly, fixed tissue was rehydrated in
methanol/PBS gradients up to 100% PBS, and
blocked in PBS/1% non-fat dry milk/0.4% Triton X-
100. This was followed by incubation with RedDot2
(1:400; Biotium, Hayward, CA, USA) fluorescent
nuclear dye, or primary antibodies targeting cytoker-
atin (CK) 5 (1:100, ab52635; AbCam, Cambridge,
UK) and CK8-18 (1:100, MS-743S; Immunologic,
Duiven, the Netherlands) in PBS/1% non-fat dry
milk/0.4% Triton X-100 for a minimum of 7 days.
After being washed in PBS/0.4% Triton X-100, speci-
mens were incubated with secondary Alexa 514-con-
jugated or Alexa 647-conjugated antibodies (1:200;
Life Technologies, Bleiswijk, the Netherlands) in PBS/
1% non-fat dry milk/0.4% Triton X-100 for 7 days.
Subsequent washing steps in PBS/0.4% Triton X-100
were followed by gradient tissue dehydration in
methanol. Prior to clearing, tissues were incubated
with a mixture of 50% methanol and 50% 1:2 benzyl
alcohol/benzyl benzoate (BABB) solution (Sigma, Zwi-
jndrecht, the Netherlands) for 10 min. Optical trans-
parency was achieved after incubation with 100%
BABB solution for 10 min. Tissue was stored in BABB
at 4°C until imaging, for a maximum of 4 weeks.
S T A I N I N G O F F F P E T I S S U E
For 3D imaging of archival FFPE prostate samples
(N = 38), areas of interest were indicated on cover-
slips of HE-stained slides derived from diagnostic
biopsies and radical prostatectomy specimens.
Punches of thickness 500 lm were collected from
the corresponding FFPE block with tissue microarray
punching needles (Estigen Tissue Science, Tartu,
Estonia). Three-dimensional immunofluorescent (IF)
tissue staining was performed according to the
iDISCO protocol.12 Briefly, tissues were dewaxed
overnight, and subsequently incubated in methanol
for 60 min, in 20% dimethylsulphoxide (DMSO) and
20% H2O2 in methanol at 4°C, and then overnight
in 20% DMSO in methanol. Tissue was rehydrated
gradually in methanol/PBS, and this was followed
by a blocking step with 0.2% Triton X-100/10%
DMSO/0.3 M glycine/PBS. Primary antibodies target-
ing CK5 (1:100) and CK8-18 (1:100) were incu-
bated for 7 days in 0.2%/Tween/20–10 lg/ml
heparin/5% DMSO/1% milk/PBS at 37°C, and this
was followed by washing in 0.2% Tween-20/20–
10 lg/ml heparin/PBS, and incubation with sec-
ondary fluorescent Alexa 514-labelled or Alexa
647-labelled antibodies (1:200; Life Technologies) in
0.2% Tween-20/10 lg/ml heparin/5% DMSO/1%
milk/PBS for 7 days at 37°C. Prior to clearing, tissue
was washed in 0.2% Tween-20/10 lg/ml heparin/
PBS overnight at 37°C, dehydrated in methanol
gradients at room temperature, and subsequently
incubated in a mixture of 50% methanol and 50%
BABB. Optical transparency was achieved in 100%
BABB solution after 10 min of incubation. After
clearing, tissue was stored for a maximum of
4 weeks in BABB at 4°C until imaging.
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C O N F O C A L M I C R O S C O P Y
For imaging, the samples were mounted in 100%
BABB in glass-bottomed microwell dishes (MatTek,
Ashland, MA, USA), and covered with #1 cover-
glasses (Menzel-Gl€aser, Braunschweig, Germany) to
avoid direct contact of the microscope objective with
BABB. Imaging was performed with an upright Leica
SP5 confocal microscope (Leica Microsystems, Eind-
hoven, the Netherlands) equipped with a 9 20
numerical aperture 1.0 APO water-dipping objective
with a 1.95-mm working distance through a 170-lm
thick coverslip. Z-stacks were recorded with a 0.72-lm
pixel size and a 1–3-lm step-size in Z, by use of a 488-
nm argon laser and a 633-nm HeNe laser. Emission
was detected in the 525–600-nm and 643–700-nm
emission ranges, respectively. To compensate for loss
of signal and optimize the collection of structural
information, laser intensity and detector sensitivity
were (semi-)automatically adjusted within a preset range.
The settings were identical in each experiment. Images
were deconvoluted with HUYGENS PROFESSIONAL
software (SVI, Hilversum, the Netherlands). Three-
dimensional rendering and image editing were performed
with FIJI (IMAGEJ 1.49s) and AMIRA (version 5.5.0; FEI,
Hillsboro, OR, USA) software.18
I M M U N O H I S T O C H E M I S T R Y
For subsequent 2D immunohistochemistry, cleared and
three-dimensionally imaged tissues were returned to
100% methanol. Methanol was replaced by ethanol, and
tissue was gradually rehydrated in PBS for re-embedding
in paraffin. Five-micrometre FFPE sections of post-cleared
tissues were deparaffinized and rehydrated with xylene
and ethanol. Endogenous peroxidase was blocked in
0.3% H2O2 in PBS, and heat-induced antigen retrieval
was performed for 15 min in Tris-EDTA buffer (pH 9;
Klinipath, Duiven, the Netherlands). Primary antibodies
targeting CK8-18 (1:500), CD31 (1:500; AbCam, Cam-
bridge, MA, USA), Ki67 (1:200; Dako, Heverlee, Belgium)
and vimentin (1:500; Dako) diluted in normal antibody
diluent (APG-500; ScyTek Laboratories, Inc, West Logan,
UT, USA) were incubated overnight at 4°C, and visual-
ized with the Envision kit (Dako). Slides were counter-
stained with haematoxylin, and visualized with an
Olympus BX41 light microscope (Olympus, Zoeterwoude,
the Netherlands).
M O L E C U L A R A N A L Y S I S
BABB-cleared tissues were placed in methanol and
rehydrated in methanol/PBS gradients. DNA from
tissue punches was isolated in lysis buffer (Promega,
Leiden, the Netherlands) containing 5% chelex (Bio-
Rad, Veenendaal, the Netherlands) with protease K
(Promega) overnight at 56°C. Protease deactivation
was achieved by heating to 95°C for 10 min. Poly-
merase chain reactions (PCRs) were performed with
primers for the housekeeping genes TBXAS1, RAG1,
PLZF and AF4 for 35 cycles at 60°C. DNA from non-
cleared FFPE prostate samples served as a control.
The DNA concentration and purity of six fresh
cleared and six FFPE cleared tissues were measured
with the Nanodrop system (Thermo Scientific, Wilm-
ington, DE, USA). As a control, 0.5-mm punches of
two non-cleared samples derived from the same
patients were included.
Results
T H R E E - D I M E N S I O N A L I M A G I N G O F F R E S H
P R O S T A T E T I S S U E
To evaluate the efficacy of tissue clearing, we first
compared fluorescent staining in cleared versus non-
cleared prostate tissue samples (N = 4). Thick tissue
slices were stained with RedDot2 and imaged with
CLSM. Nuclear RedDot2 signals could be detected
throughout the whole BABB-cleared tissue slice of
800 lm. Without tissue clearing, the Reddot2 signal
was lost at 70 lm within the tissue, and was only
visible at the edges of the tissue up to a depth of
200 lm in the image stack (Figure 1; Figure S1).
To gain insights into 3D normal and malignant
prostate glandular architecture, we performed IF dou-
ble-staining for CK5 and CK8-18.19,20 In general,
CK5 labels pre-existing basal cells surrounding CK8-
18-positive luminal epithelial cells in benign prostate
glands. By using IF double-labelling, we were able to
routinely image approximately 500-lm-thick tissues
with sufficient signal throughout the stack. In the
transition zone, 2D well-delineated round glandular
structures were represented in three dimensions by
organized acini (Figure 2A–D; Video S1). In the
peripheral zone, 2D longitudinal tubule sections cor-
responded to 3D slit-like angulated tubular spaces
(Figure 2E–H; Video S2).
T H R E E - D I M E N S I O N A L I M A G I N G O F F F P E
P R O S T A T E T I S S U E
The feasibility of clearing and 3D imaging on archival
FFPE tissue samples was investigated on selected
Gleason grade patterns of PCa as identified in 2D HE
slides. PCa almost exclusively consists of CK8-18-
© 2016 John Wiley & Sons Ltd, Histopathology
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positive luminal cells, lacking a CK5-positive basal
cell layer.19,20 Figure 3A–D demonstrates closely
packed well-delineated glands corresponding to Glea-
son score 3 + 3 = 6 PCa; on HE staining, branching
and anastomosing of glands was not observed. How-
ever, 3D IF imaging showed that respective PCa
glands represented an interconnecting glandular net-
work (Video S3). A Gleason score 7 PCa consisting of
well-delineated Gleason pattern 3 glands and Gleason
pattern 4 with intraluminal glomeruloid epithelial
proliferations is shown in Figure 3E–H (Video S4).
Three-dimensional projection revealed that the glan-
dular structures with intraluminal glomeruloid
proliferations were continuous with well-delineated
Gleason grade 3 glands, which was not appreciated
in the corresponding HE slide. Figure 3J–L depicts an
area of ill-defined Gleason pattern 4 PCa glands.
Three-dimensional analysis revealed that these struc-
tures represented a highly anastomosing meshwork
of small-sized tubules and cords of malignant cells
(Video S5). The interobserver variability of ill-defined
tumour glands is relatively poor, as discriminating
them from tangentially sectioned Gleason grade 3 or
Gleason grade 5 glands is often difficult.21 Three-
dimensional imaging was able to separate well-
delineated Gleason grade 3 glands (Figure 3A–D)
Non-cleared Cleared
BA
Figure 1. Tissue clearing of
fresh clinical prostate cancer
tissue. A three-dimensional
projection of fluorescent
images (Figure S1) of nuclear
Reddot2 in non-cleared (A)
and benzyl alcohol/benzyl
benzoate-cleared (B) clinical
prostate tissue showed that
tissue clearing enhanced the
depth of imaging up to
0.8 mm. Scale bars: 100 lm.
A B C D
E F G H
Figure 2. Three-dimensional (3D) imaging of antibody-stained fresh samples of benign prostate transition zone (A–D) and peripheral zone
(E–H). A,E, Reference haematoxylin and eosin slide. B,F, Single two-dimensional optical plane of immunofluorescent cytokeratin (CK) 8-18-
labelled (green) and CK5-labelled (red), benzyl alcohol/benzyl benzoate-cleared tissue. C,G,D,H, Three-dimensional projection (C,G) and 3D
binary projection (D,H) of approximately 500-lm-thick tissue samples. Scale bars: 100 lm.
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from an ill-defined Gleason grade 4 growth pattern
(Figure 3J–L) on the basis of the large number of
small anastomosing tubules in the latter.
T I S S U E P R O C E S S I N G A F T E R 3 D I M A G I N G
To determine whether 2D immunohistochemistry and
molecular analysis were still possible after 3D IF and
BABB clearing, we rehydrated and paraffin-embedded
three-dimensionally imaged tissue samples. Tissue
morphology on HE staining before and after 3D pro-
cessing was comparable. Conventional immunohisto-
chemical staining for CK8-18, CD31, Ki67 and
vimentin demonstrated that specific protein labelling
after 3D imaging was still feasible (Figure 4A).
However, respective stainings demonstrated cytoplas-
mic labelling of basal epithelial cells in fresh tissue,
which was attributable to shared primary antibody
species with the CK5 antibody that was used for 3D
IF imaging prior to conventional 2D staining (Fig-
ure S2C). After BABB clearing and 3D imaging, the
DNA yield was sufficient for multiple molecular anal-
ysis (range 68.4–202.7 ng/ll), with minor loss of
purity (range 0.7–1.1 ng/ll) (Table 1). DNA quality
was sufficient for PCR amplification and analysis,
with some degradation as compared with non-cleared
control tissue (Figure 4B; Figure S2D). In contrast,
RNA isolation resulted in small quantities of mostly
degraded RNA (data not shown), which was not suffi-
cient for RNA analysis.
B C D
F G H
J
A
E
I K L
Figure 3. Three-dimensional (3D) pathology of prostate cancer growth patterns. A–D, Well-delineated Gleason grade 3 prostate cancer with
regular 3D glandular interconnections. E–H, Well-delineated Gleason grade 3 and glomeruloid Gleason grade 4 glands. Three-dimensional
spatial transitions between both structures exist. I–L, Three-dimensional projection of an ill-defined Gleason grade 4 gland demonstrates a
highly interconnecting meshwork of small-sized tubules and cords. Vertical panels from left to right represent a reference haematoxylin and
eosin slide, a single 2D optical plane of immunofluorescent cytokeratin (CK) 8-18-labelled (green) and CK5-labelled (red) benzyl alcohol/ben-
zyl benzoate-cleared tissue, and original 3D and 3D binary projections. Scale bars: 100 lm.
© 2016 John Wiley & Sons Ltd, Histopathology
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Discussion
In this study, we have demonstrated that BABB-
mediated tissue clearing can successfully be applied for
3D imaging of fresh and FFPE clinical prostate speci-
mens up to a depth of ~800 lm. The feasibility of this
methodology for FFPE tissues, in particular, offers the
opportunity to study specific pathological and biological
features of interest in their 3D context. Moreover, 3D
imaging has been raised as a novel diagnostic tissue-
processing methodology.22 We have also shown that,
after 3D imaging, tissue samples are still suitable for
routine 2D processing, including immunohistochem-
istry and molecular analysis, which is relevant in cases
of unique tissue samples and/or small tissue fragments.
We were able to image small nuclear dyes as well
as antibodies, visualizing the 3D microscopic
structure of both benign and malignant human pros-
tate samples. We set out to develop 3D imaging in
clinical prostate tissues to obtaing more profound
insights into the PCa growth patterns underlying the
current Gleason grading system. Although the cur-
rent study was not aimed at performing detailed
characterization of various growth patterns, we were
able to preliminarily interpret a subset of growth pat-
terns. That is, we have shown that: (i) Gleason grade
3 glands are branching and connecting; (ii) glomeru-
loid structures are continuous with delineated Glea-
son grade 3 glands; and (iii) ill-defined Gleason grade
4 glands represent small tubules with more frequent
interconnections.
Several approaches have been applied for 3D imag-
ing of tissues. Although these technologies have pro-
ven to be valuable for non-invasive imaging of
tissues, they are not based on labelling and visualiza-
tion of specific (disease-related) structures [e.g. mag-
netic resonance imaging (MRI), (micro-)Raman
spectroscopy, and optical coherence tomography], or
do not reveal sufficient detail of microscopic struc-
tures in tissues (MRI and fluorescence tomography).
Tissue-clearing techniques enable the visualization of
(disease)-specific structures while still maintaining the
microscopic detail, as we have demonstrated in this
study, thus offering an opportunity for diagnostic
pathology in the future. Importantly, Torres et al.
demonstrated comparable morphology between
CK8-18 CD31
KI67 Vimentin
No
n-
cle
ar
ed
 
Cl
ea
re
d
TBXAS1
RAG1
PLZF
AF4
BA
Figure 4. Processing of cleared formalin-fixed paraffin-embedded archival prostate cancer tissue. A, Immunohistochemical cytokeratin (CK)
8-18, CD31, Ki67 and vimentin staining of cleared, re-embedded tissue sections demonstrates labelling of luminal epithelium, endothelium,
proliferating cells, and stromal cells (arrowheads). B, Routine quality polymerase chain reaction on DNA isolated from cleared tissue samples
shows the applicability of molecular analysis after three-dimensional imaging, despite some degradation as compared with control non-
cleared tissue.
Table 1. DNA yield and purity of cleared and uncleared
tissues
Yield in ng/ll (SD) Purity (SD)
FFPE cleared (n = 6) 68.4 (13.9) 0.7 (0.0)
FFPE uncleared (n = 2) 145.8 (41.2) 1.0 (0.1)
Fresh cleared (n = 6) 202.7 (96.2) 1.1 (0.2)
Fresh uncleared (n = 2) 163.7 (2.9) 1.1 (0.0)
FFPE, formalin-fixed paraffin-embedded; SD, standard deviation.
© 2016 John Wiley & Sons Ltd, Histopathology
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reference HE 2D slides and BABB-cleared 800-lm-
thick samples imaged by multiphoton microscopy
with pseudocolouring.22 The advantages of such an
approach would be that tissue samples remain intact
and that no material is lost during tissue processing.
We have shown that 2D immunohistochemistry and
molecular analysis can still be performed on optically
cleared tissue used for 3D imaging. With the current
technological advancements in view, including deep
tissue scanning and fast staining protocols, imaging
of intact tissue samples might become an alternative
to traditional 2D HE-stained tissue slides and corre-
sponding tissue loss in the future.
Although passive antibody diffusion in complete tis-
sue samples is time-consuming and is a limitation in
this study, significant improvements in the staining
protocol, including staining in high-pressure condi-
tions, could well result in improved antibody penetra-
tion, and enable the visualization of 3D structures in
even larger tissue samples. Second, the interpretation
and quantification of both 3D and 2D growth pat-
terns is subjective, emphasizing the need for more
objective image analysis approaches to more objec-
tively describe and separate tissue structures.
In conclusion, we have described a methodology
for clearing and 3D imaging of fresh and FFPE pros-
tate specimens up to a depth of 800 lm. This
methodology allows 3D analysis of an unlimited
range of normal and pathological structures in clini-
cal tissue specimens. The procedure is compatible
with subsequent tissue sectioning, 2D (immuno)histo-
chemistry, and molecular analysis, allowing multiple
analyses on limited tissue samples.
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Supporting Information
Additional Supporting Information may be found in
the online version of this article:
Figure S1. Tissue clearing of fresh clinical prostate
cancer tissue.
Figure S2. Processing of cleared fresh fixed tissue.
Video S1. 3D binary projection of cleared prostate
transition zone; CK8-18 (green) and CK5 (red).
Video S2. 3D binary projection of cleared prostate
peripheral zone; CK8-18 (green) and CK5 (red).
Video S3. 3D binary projection of cleared Gleason
grade 3; CK8-18 (green) and CK5 (red).
Video S4. 3D binary projection of cleared Gleason
grade 3 and glomeruloid Gleason grade 4; CK8-18
(green) and CK5 (red).
Video S5. 3D binary projection of cleared ill-formed
Gleason grade 4; CK8-18 (green) and CK5 (red).
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